EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current cell therapies for systemic lupus erythematosus

Lan T M Dao iD, Thu Thuy Vu, Quyen Thi Nguyen, Van T Hoang, Thanh Liem Nguyen iD

Stem Cells Translational Medicine · 10.09.2024 · 13 (9) · 859-872

DOI: 10.1093/stcltm/szae044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 26.06.2024. Verfasst von Lan T M Dao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vinmec Research Institute of Stem Cell and Gene Technology, Vinmec Healthcare System, Hanoi 100000, Vietnam. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which multiple organs are damaged by the immune system. Although standard treatment options such as hydroxychloroquine (HCQ), glucocorticoids (GCs), and other immunosuppressive or immune-modulating agents can help to manage symptoms, they do not offer a cure. Hence, there is an urgent need for the development of novel drugs and therapies. In recent decades, cell therapies have been used for the treatment of SLE with encouraging results. Hematopoietic stem cell transplantation, mesenchymal stem cells, regulatory T (Treg) cell, natural killer cells, and chimeric antigen receptor T (CAR T) cells are advanced cell therapies which have been developed and evaluated in clinical trials in humans. In clinical application, each of these approaches has shown advantages and disadvantages. In addition, further studies are necessary to conclusively establish the safety and efficacy of these therapies. This review provides a summary of recent clinical trials investigating cell therapies for SLE treatment, along with a discussion on the potential of other cell-based therapies. The factors influencing the selection of common cell therapies for individual patients are also highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicCell- and Tissue-Based TherapyHumansMesenchymal Stem Cell TransplantationHematopoietic Stem Cell TransplantationT-Lymphocytes, RegulatoryAnimalsKiller Cells, Natural

Stichwörter der Autor:innen

cell therapychimeric antigen receptor T-cell therapyclinical trialhematopoietic stem cell transplantationmesenchymal stem cell therapysystemic lupus erythematosus

Autor:innen und Institutionen

  • Vinmec Research Institute of Stem Cell and Gene Technology, Vinmec Healthcare System, Hanoi 100000, Vietnam.
  • Vinmec International Hospital, Center of Regenerative Medicine and Cell Therapy, Vinmec Healthcare System, Hanoi 100000, Vietnam.
  • Vin University, College of Health Sciences, Hanoi 100000, Vietnam.

ORCID-Profile: Lan T M Dao, Thanh Liem Nguyen

Zitieren

APA

Dao, L. T. M., Vu, T. T., Nguyen, Q. T., Hoang, V. T., & Nguyen, T. L. (2024). Current cell therapies for systemic lupus erythematosus. Stem Cells Translational Medicine, 13(9), 859-872. https://doi.org/10.1093/stcltm/szae044

Vancouver

Dao LTM, Vu TT, Nguyen QT, Hoang VT, Nguyen TL. Current cell therapies for systemic lupus erythematosus. Stem Cells Translational Medicine. 2024;13(9):859-872. doi:10.1093/stcltm/szae044

BibTeX
@article{Dao2024,
  author = {Dao, Lan T M and Vu, Thu Thuy and Nguyen, Quyen Thi and Hoang, Van T and Nguyen, Thanh Liem},
  title = {Current cell therapies for systemic lupus erythematosus},
  journal = {Stem Cells Translational Medicine},
  year = {2024},
  volume = {13},
  number = {9},
  pages = {859--872},
  doi = {10.1093/stcltm/szae044}
}
Kostenlos starten →